Schott Pharma AG & CO KGaA (1SXP)
TG
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current 1SXP market cap is 3.54B. The company's latest EPS is EUR 1.0081 and P/E is 23.73.
| Year End September 29 2023 | 2023 |
|---|---|
| EUR (€) | |
| Total Revenue | 898.6M |
| Operating Income | 189.28M |
| Net Income | 151.84M |
| Year End September 29 2023 | 2023 |
|---|---|
| EUR (€) | |
| Total Assets | 1.23B |
| Total Liabilities | 539.65M |
| Total Equity | 692.18M |
| Year End September 29 2023 | 2023 |
|---|---|
| EUR (€) | |
| Operating | 181.65M |
| Investing | -171.41M |
| Financing | -11.4M |
| Market Cap | 3.54B |
| Price to Earnings Ratio | 23.73 |
| Price to Sales Ratio | 4.01 |
| Price to Cash Ratio | 147.93 |
| Price to Book Ratio | 5.2 |
| Dividend Yield | 0.68% |
| Shares Outstanding | 150.62M |
| Average Volume (1 week) | 4.71k |
| Average Volume (1 Month) | 6.53k |
| 52 Week Change | -31.63% |
| 52 Week High | 43.20 |
| 52 Week Low | 22.78 |
| Spread (Intraday) | 0.38 (1.6%) |
| Company Name | Schott Pharma AG & CO KGaA |
| Address |
hattenbergstrasse 10 mainz 55122 |
| Website | https://www.schott-pharma.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
